(VIR) Vir Biotechnology - Performance -38.3% in 12m
VIR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-87.82%
#168 in Peer-Group
Rel. Strength
13.46%
#6632 in Stock-Universe
Total Return 12m
-38.32%
#109 in Peer-Group
Total Return 5y
-88.75%
#110 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 4.36 |
| High / Low | USD |
|---|---|
| 52 Week High | 12.48 USD |
| 52 Week Low | 4.50 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 82.49 |
| Buy/Sell Signal +-5 | -1.84 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VIR (-38.3%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: VIR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VIR
| Total Return (including Dividends) | VIR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 7.62% | 3.15% | 4.01% |
| 3 Months | 2.17% | 17.08% | 17.14% |
| 12 Months | -38.32% | -11.14% | 13.46% |
| 5 Years | -88.75% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | VIR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 55.5% | 52.1% | 90.3% |
| 3 Months | -31.6% | 79.4% | 97.5% |
| 12 Months | -68.4% | -87.4% | 46.4% |
| 5 Years | -92% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th67.00 | 4.33% | 3.47% |
| 3 Month | %th28.50 | -12.74% | -12.78% |
| 12 Month | %th45.50 | -30.59% | -45.64% |
| 5 Years | %th43.00 | -85.58% | -94.71% |
FAQs
Does Vir Biotechnology (VIR) outperform the market?
No,
over the last 12 months VIR made -38.32%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months VIR made 2.17%, while XBI made 17.08%.
Performance Comparison VIR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VIR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6.7% | 3.6% | -54.2% | -52% |
| US NASDAQ 100 | QQQ | 6.8% | 3.4% | -56.2% | -52% |
| German DAX 40 | DAX | 6.4% | 6.4% | -66.3% | -69% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.6% | 3.1% | -58.6% | -57% |
| Hongkong Hang Seng | HSI | 5.9% | 4.8% | -76.2% | -73% |
| India NIFTY 50 | INDA | 8.1% | 8.4% | -54.6% | -35% |
| Brasil Bovespa | EWZ | 11% | 8.3% | -69.2% | -40% |
VIR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 8.1% | 5.9% | -57.5% | -62% |
| Consumer Discretionary | XLY | 5.8% | 4.3% | -46.5% | -57% |
| Consumer Staples | XLP | 8.8% | 7.8% | -53.3% | -46% |
| Energy | XLE | 3.8% | 3.5% | -46.6% | -40% |
| Financial | XLF | 8.2% | 5% | -56.5% | -64% |
| Health Care | XLV | 6.6% | 7.6% | -42.7% | -32% |
| Industrial | XLI | 6.3% | 3.2% | -60% | -62% |
| Materials | XLB | 6.1% | 3.1% | -54.8% | -42% |
| Real Estate | XLRE | 7% | 7.8% | -52.7% | -47% |
| Technology | XLK | 6.9% | 1% | -59.3% | -49% |
| Utilities | XLU | 6.7% | 5% | -58.2% | -58% |
| Aerospace & Defense | XAR | 6.1% | 0.8% | -74.2% | -87% |
| Biotech | XBI | 3.1% | 4.5% | -43.9% | -27% |
| Homebuilder | XHB | 3.7% | -1.1% | -47.6% | -37% |
| Retail | XRT | 6.8% | 4.4% | -49.4% | -45% |
VIR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6.2% | 4.32% | -40.3% | -34% |
| Natural Gas | UNG | 8.5% | 14.1% | -28.2% | -36% |
| Gold | GLD | 6.6% | 7.4% | -72.1% | -77% |
| Silver | SLV | 2.4% | 1.3% | -76.2% | -60% |
| Copper | CPER | -3.6% | -7.3% | -73.7% | -62% |
VIR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 7.6% | 7.7% | -48.9% | -34% |
| iShares High Yield Corp. Bond | HYG | 7.3% | 6.5% | -51.2% | -47% |